Audrius Ivanauskas
Kaunas, KU, Lithuania
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Efficacy and Safety of the Anti-IL1RAP Antibody Nadunolimab (CAN04) in Combination with Gemcitabine and Nab-Paclitaxel in Patients with Advanced/Metastatic Pancreatic Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: March 02, 2024
Identification of Recessively Inherited Genetic Variants Potentially Linked to Pancreatic Cancer Risk.
Journal: Frontiers in oncology
Published: September 06, 2021
Association of Genetic Variants Affecting microRNAs and Pancreatic Cancer Risk.
Journal: Frontiers in genetics
Published: April 12, 2021
Laparoscopic versus open surgery for gastric cancer: the experience of one European centre.
Journal: Przeglad gastroenterologiczny
Published: October 29, 2020
Genome-wide scan of long noncoding RNA single nucleotide polymorphisms and pancreatic cancer susceptibility.
Journal: International journal of cancer
Published: August 31, 2020
Polygenic and multifactorial scores for pancreatic ductal adenocarcinoma risk prediction.
Journal: Journal of medical genetics
Published: February 26, 2020
Genome-wide association study identifies an early onset pancreatic cancer risk locus.
Journal: International journal of cancer
Published: July 18, 2019
Germline BRCA2 K3326X and CHEK2 I157T mutations increase risk for sporadic pancreatic ductal adenocarcinoma.
Journal: International journal of cancer
Published: July 30, 2018
Functional single nucleotide polymorphisms within the cyclin-dependent kinase inhibitor 2A/2B region affect pancreatic cancer risk.
Journal: Oncotarget
Published: May 09, 2016
TERT gene harbors multiple variants associated with pancreatic cancer susceptibility.
Journal: International journal of cancer
Published: July 14, 2014
Last Updated: 09/26/2026